D-1435-2019 Class II Terminated
FDA drug recall D-1435-2019 was initiated by Baxter Healthcare Corporation on June 13, 2019 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated April 29, 2020). Affected quantity: 5940 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- June 19, 2019
- Initiation Date
- June 13, 2019
- Termination Date
- April 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5940 bottles
Product Description
Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64
Reason for Recall
Failed Stability Specifications
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: S110F822 Exp. 5/31/2021